Multiple myeloma (MM) is a type of cancer that affects plasma cells in the bone marrow, leading to various complications, including bone lesions and organ damage. Imaging techniques play a crucial ...

Imaging tests provide pictures of the tissues inside your body. These can help your healthcare team determine if you have multiple myeloma and how far it may have spread throughout your body. Imaging ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

This review summarizes the mechanisms of action and clinical activity of IMiDs in MM. Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic ...

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

Kyphoplasty has also increasingly been used to treat vertebral osteolyses caused by multiple myeloma (MM). Patients and Methods: In our cohort of 76 patients with MM with a total of 190 vertebral ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.